Neuronal Vulnerability of the Entorhinal Cortex to Tau Pathology in Alzheimer’s Disease
British Journal of Biomedical Science · 07.10.2024 · 81
DOI: 10.3389/bjbs.2024.13169 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift British Journal of Biomedical Science, online erschienen am 07.10.2024. Verfasst von Simi Zhang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Biomedical Sciences, Faculty of Medicine, Memorial University of Newfoundland, St. John's, NL, Canada. Hauptthemen laut MEDLINE: Alzheimer Disease, Entorhinal Cortex, tau Proteins, Neurons. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 93 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Alzheimer’s Society.
Themen: Demenz
Abstract (Originalsprache)
This review delves into the entorhinal cortex (EC) as a central player in the pathogenesis of Alzheimer’s Disease (AD), emphasizing its role in the accumulation and propagation of tau pathology. It elucidates the multifaceted functions of the EC, encompassing memory formation, spatial navigation, and olfactory processing, while exploring how disruptions in these processes contribute to cognitive decline in AD. The review discusses the intricate interplay between tau pathology and EC vulnerability, highlighting how alterations in neuronal firing patterns and synaptic function within the EC exacerbate cognitive impairments. Furthermore, it elucidates how specific neuronal subtypes within the EC exhibit differential susceptibility to tau-induced damage, contributing to disease progression. Early detection methods, such as imaging techniques and assessments of EC blood flow, are examined as potential tools for identifying tau pathology in the preclinical stages of AD. These approaches offer promise for improving diagnostic accuracy and enabling timely intervention. Therapeutic strategies targeting tau pathology within the EC are explored, including the clearance of pathological tau aggregates and the inhibition of tau aggregation processes. By understanding the molecular and cellular mechanisms underlying EC vulnerability, researchers can develop more targeted and effective interventions to slow disease progression. The review underscores the importance of reliable biomarkers to assess disease progression and therapeutic efficacy in clinical trials targeting the EC. Ultimately, it aims to contribute to the development of more effective management strategies for AD, emphasizing the translation of research findings into clinical practice to address the growing societal burden of the disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Biomedical Sciences, Faculty of Medicine, Memorial University of Newfoundland, St. John's, NL, Canada.
Förderung
- Alzheimer’s Society
Zitieren
APA
Zhang, S., Crossley, C. A., & Yuan, Q. (2024). Neuronal Vulnerability of the Entorhinal Cortex to Tau Pathology in Alzheimer’s Disease. British Journal of Biomedical Science, 81. https://doi.org/10.3389/bjbs.2024.13169
Vancouver
Zhang S, Crossley CA, Yuan Q. Neuronal Vulnerability of the Entorhinal Cortex to Tau Pathology in Alzheimer’s Disease. British Journal of Biomedical Science. 2024;81. doi:10.3389/bjbs.2024.13169
BibTeX
@article{Zhang2024,
author = {Zhang, Simi and Crossley, Chelsea Ann and Yuan, Qi},
title = {Neuronal Vulnerability of the Entorhinal Cortex to Tau Pathology in Alzheimer’s Disease},
journal = {British Journal of Biomedical Science},
year = {2024},
volume = {81},
doi = {10.3389/bjbs.2024.13169}
}
EUVIMED